Associated Papers
Treatment-emergent neuroendocrine prostate cancer with a germline BRCA2 mutation: identification of a candidate reversion mutation associated with platinum/PARP-inhibitor resistance.
Pandya D et al.
Cold Spring Harbor Molecular Case Studies, 2021
Select a paper to view details